Home > Insider Trading > Filing (0001415889-24-025140)

Filing Details

Accession Number:: 0001415889-24-025140
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-15 17:56:35
Reporting Period:: 2024-10-15

Accepted Time:: 2024-10-15 17:56:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736730	Camp4 Therapeutics Corp	CAMP	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1664281	Kush Parmar	C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1753037	5Am Ventures Vi, L.p.	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1829051	5Am Partners Vi, Llc	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	No	No
1844401	5Am Opportunities Ii, L.p.	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1873515	5Am Opportunities Ii (Gp), Llc	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-15	1,716,055	$0.00	1,716,055	No	4	C	Indirect	By 5AM Ventures VI, L.P.
Common Stock	Acquisiton	2024-10-15	302,770	$0.00	302,770	No	4	C	Indirect	By 5AM Opportunities II, L.P.
Common Stock	Acquisiton	2024-10-15	909,090	$11.00	2,625,145	No	4	P	Indirect	By 5AM Ventures VI, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By 5AM Ventures VI, L.P.
No	4	C	Indirect	By 5AM Opportunities II, L.P.
No	4	P	Indirect	By 5AM Ventures VI, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Prime Preferred Stock	Disposition	2024-10-15	15,002,166	$0.00	1,337,592	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	4,244,770	$0.00	378,463	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	3,395,816	$0.00	302,770	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.